Company: INTS
Filing Date: 2025-04-22
Form Type: S-1
Source: 0001628280-25-018892
Chunk: 66

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-04-22
Form: S-1
Chunk 66
---
) 12,500 warrants to purchase shares of Common Stock at an exercise price of $2.00 by a consultant, and (ii) 12,500 options to purchase shares of Common Stock at an exercise price of $2.00 by a consultant.

In October 2023, we granted an aggregate of 116,000 warrants (the “Consultant Warrants”) to purchase shares of its Common Stock to three consultants of the Company in consideration of their services to the Company. The Consultant Warrants have an expiration date ten years from the grant date, and have an exercise price of $6.13. The vesting schedule for the Consultant Warrants are as follows: (i) two of the three consultants have 4,000 Consultant Warrants that vested immediately on the grant date and (ii) each of the three Consultants will have 36,000 of their warrants vest in equal monthly installments, beginning one month from the grant date.

In March 2024, we granted warrants (the “Consultant Warrants”) to purchase an aggregate of 25,000 shares of our Common Stock to three consultants in consideration of their services. The Consultant Warrants have an expiration date ten years from the grant date, have an exercise price of $5.19 per share, and will vest in four equal annual installments, beginning one year from the grant date.

In March 2024, we received aggregate proceeds of $7,500 upon the exercise of warrants to purchase 2,500 shares of Common Stock at an exercise price of $3.00 per share.

In September 2024, we issued 11,750 restricted shares of its Common Stock to a consultant as compensation for its services to the Company through the end October 2024.

In November 2024, we issued warrants exercisable for an aggregate of 1,237,113 shares of Common Stock at an exercise price of $2.95.

The above securities were issued without registration under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws in a transaction not involving a public offering and the Sellers represented they are an accredited investor. We relied on the exclusion from the registration requirements of the Securities Act of 1933 afforded by Section 4(a)(2).

## Item 16. Exhibits
(a)The following exhibits are filed herewith or incorporated herein by reference:

#### EXHIBIT INDEX
| EXHIBIT NUMBER |     | EXHIBIT DESCRIPTION